>
Fa   |   Ar   |   En
   Bispecific antibodies (bsAbs): Promising immunotherapeutic agents for cancer therapy  
   
نویسنده acheampong d.o. ,adokoh c.k. ,ampomah p. ,agyirifo d.s. ,dadzie i. ,ackah f.a. ,asiamah e.a.
منبع protein and peptide letters - 2017 - دوره : 24 - شماره : 5 - صفحه:456 -465
چکیده    Antibodies have become the preferred therapeutic treatment option for cancers. antibody therapy is associated with low toxic profile and specific in its activity,unlike chemotherapy and radiotherapy. types of tumor are known to express multiple receptors that cross-talk to activate perpetual growth,proliferation and metastasis,and inhibit apoptosis in such tumors. bispecific antibodies (bsabs) are therefore the preferred agent for the treatment of such cancers due to its unique characteristics. this review discusses up to date therapeutic potentials of bsabs. © 2017 bentham science publishers.
کلیدواژه Antibody; Antitumor; Bispecific antibody (BsAb); Cancer therapy; Diabody; Immunotherapeutic agent
آدرس department of biomedical sciences,school of allied health sciences,university of cape coast,cape coast, Ghana, department of forensic sciences,school of biological sciences,university of cape coast,cape coast, Ghana, department of biomedical sciences,school of allied health sciences,university of cape coast,cape coast, Ghana, department of molecular biology and biotechnology,school of biological sciences,university of cape coast,cape coast, Ghana, department of medical laboratory technology,school of allied health sciences,university of cape coast,cape coast, Ghana, department of biomedical sciences,school of allied health sciences,university of cape coast,cape coast, Ghana, department of forensic sciences,school of biological sciences,university of cape coast,cape coast, Ghana
 
     
   
Authors
  
 
 

Copyright 2023
Islamic World Science Citation Center
All Rights Reserved